Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

A Robust Long Non-Coding RNA Expression Classifier for Risk Stratification in Pediatric AML

Jason E Farrar, Jenny L. Smith, Megan Othus, Benjamin J. Huang, Yi-Cheng Wang, Rhonda E. Ries, Tiffany A. Hylkema, Era L Pogosova-Agadjanyan, Sneha Challa, Amanda R. Leonti, Timothy I. Shaw, Timothy Junius Triche, Jr., Alan S. Gamis, Richard Aplenc, Anders E. Kolb, Xiaotu Ma, Derek Stirewalt, Todd A. Alonzo, Soheil Meshinchi

Blood (2022) 140 (Supplement 1): 9173–9174.

https://doi.org/10.1182/blood-2022-168296

Published: 2022

Journal Articles

Global Proteomic Profiling Identifies Novel Prognostic Factors in Undifferentiated Leukemia Blasts from Patients with NPM1 Mutations: A Previously Unreported Approach to Biomarker Discovery from the Fred Hutch and SWOG

Blood (2021) 138 (Supplement 1): 799.

https://doi.org/10.1182/blood-2021-151678

Published: 2021

Journal Articles

Proteogenomic Characterization of Highly Enriched Viable Leukemic Blasts in Acute Myeloid Leukemia: A SWOG Report

Blood (2021) 138 (Supplement 1): 522.

https://doi.org/10.1182/blood-2021-151246

Published: 2021

Journal Articles

Characteristics and Prognostic Effects of IDH Mutations across the Age Spectrum in AML: A Collaborative Analysis from COG, SWOG, and ECOG

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-134211

Published: 2020

Journal Articles

Development and Performance of Risk Stratification Models for AML Patients Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG Report

Blood (2019) 134 (Supplement_1): 2691.

https://doi.org/10.1182/blood-2019-124529

Published: 2019

Journal Articles

Improved Prognostic Significance of Genomic and Transcriptional Biomarkers By Examining Enriched Populations of AML Blasts: A SWOG Report

Era L. Pogosova-Agadjanyan, Anna Moseley, Brent L. Wood, MD PhD, Frederick R. Appelbaum, Thomas Chauncey, I-Ming L. Chen, DVM, MS, Harry P. Erba, MD PhD, John E. Godwin, Min Fang, Kenneth J. Kopecky, Alan F. List, Megan Othus, Jerald P. Radich, Cheryl L. Willman, Soheil Meshinchi, Derek L. Stirewalt

Blood (2016) 128 (22): 2890.

https://doi.org/10.1182/blood.V128.22.2890.2890

Published: 2016

Journal Articles

Prognostic Significance Of NPM1 mutations In The Absence Of FLT3 -ITD in Older Patients With AML: A SWOG Report

Fabiana Ostronoff, MD, Megan Othus, PhD, Soheil Meshinchi, MD, PhD, John E. Godwin, MD, MS, Kenneth J. Kopecky, PhD, Alan List, MD, Vivian G. Oehler, MD, Stephen Petersdorf, MD, Era L. Pogosova-Agadjanyan, Jerald Radich, MD, Cheryl L. Willman, MD, Frederick R. Appelbaum, MD, Derek L. Stirewalt, MD

Blood (2013) 122 (21): 1315.

https://doi.org/10.1182/blood.V122.21.1315.1315

Published: 2013

Journal Articles

Novel IL23R Splice Variant Is Associated with Worse Prognosis in Pediatric Patients with AML.

Derek L. Stirewalt, MD, Todd A. Alonzo, PhD, Era L. Pogosova-Agadjanyan, Robert B. Gerbing, M.A., Janet Franklin, MD, MPH, Susana C. Raimondi, Betsy A. Hirsch, PhD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 2546.

https://doi.org/10.1182/blood.V120.21.2546.2546

Published: 2012

Journal Articles

Novel IRF8 Splice Variants Are Validated As a New Prognostic Biomarker for Adverse Outcome in an Independent Population of Pediatric Patients with AML.

Derek L. Stirewalt, MD, Todd A. Alonzo, PhD, Era L. Pogosova-Agadjanyan, Robert B. Gerbing, M.A., Janet Franklin, MD, MPH, Hana Lee, Susana C. Raimondi, Betsy A. Hirsch, PhD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 2550.

https://doi.org/10.1182/blood.V120.21.2550.2550

Published: 2012

Journal Articles

Expression Differences of Prognostic Biomarkers in Mononuclear Cells (MNCs) and Malignant Blasts of Acute Myeloid Leukemia (AML) Patients

Era L. Pogosova-Agadjanyan, Soheil Meshinchi, MD, Ph.D., Hana Lee, Brent L. Wood, MD, PhD, Derek L. Stirewalt, MD

Blood (2011) 118 (21): 1468.

https://doi.org/10.1182/blood.V118.21.1468.1468

Published: 2011

Journal Articles

Prognostic Significance of FLT3 and NPM1 Mutations in Adults of Age 18–60 with De Novo Acute Myeloid Leukemia (AML) on SWOG S0106 Study: A Study by FHCRC and SWOG

Era L. Pogosova-Agadjanyan, Kenneth J. Kopecky, PhD, Stephen Petersdorf, MD, Harry Paul Erba, MD, PhD, Richard M. Stone, MD, Soheil Meshinchi, MD, PhD, Thomas J. Nevill, MD, FRCPC, Jerald P. Radich, MD, Leif Stenke, MD, PhD, Marilyn L Slovak, PhD, Robert K Stuart, MD, Martin S. Tallman, MD, Cheryl L Willman, MD, Rebecca M. Mortensen, Breanna L. Wentz, Frederick R. Appelbaum, MD, Derek L. Stirewalt, MD

Blood (2011) 118 (21): 2520.

https://doi.org/10.1182/blood.V118.21.2520.2520

Published: 2011

Journal Articles

Over-Expression of Novel IRF8 Splice Variants Is Associated with a Significant Decrease In Relapse-Free Survival In Adult AML Patients.

Era L. Pogosova-Agadjanyan, Kenneth J. Kopecky, PhD, Hana Lee, Jeanne E. Anderson, MD, John E. Godwin, MD, MS, Alan F. List, Soheil Meshinchi, MD, PhD, Vivian Oehler, MD, Stephen H. Petersdorf, MD, Cheryl L. Willman, MD, Frederick R. Appelbaum, MD, Jerald P. Radich, MD, Derek L. Stirewalt, MD

Blood (2010) 116 (21): 1679.

https://doi.org/10.1182/blood.V116.21.1679.1679

Published: 2010

Journal Articles

Methylation Regulates Expression of Novel Splice Variant and Wild Type Transcripts of IRF8.

Era L. Pogosova-Agadjanyan, Hana Lee, Crystal K. Cummings, Soheil Meshinchi, MD, PhD, Jerald P. Radich, MD, Derek L. Stirewalt, MD

Blood (2010) 116 (21): 3634.

https://doi.org/10.1182/blood.V116.21.3634.3634

Published: 2010

Journal Articles

Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia

Olga Sala-Torra, Holly M. Gundacker, Derek L. Stirewalt, Paula A. Ladne, Era L. Pogosova-Agadjanyan, Marilyn L. Slovak, Cheryl L. Willman, Shelly Heimfeld, David H. Boldt, Jerald P. Radich

Blood (2006) 109 (7): 3080–3083.

https://doi.org/10.1182/blood-2006-06-031096

Published: 2006

Journal Articles

Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia

Derek L. Stirewalt, Kenneth J. Kopecky, Soheil Meshinchi, Julia H. Engel, Era L. Pogosova-Agadjanyan, Jeremy Linsley, Marilyn L. Slovak, Cheryl L. Willman, Jerald P. Radich

Blood (2006) 107 (9): 3724–3726.

https://doi.org/10.1182/blood-2005-08-3453

Published: 2006

Includes: Supplemental data

Journal Articles

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia.

Olga Sala-Torra, MD, Holly M. Gundacker, Derek L. Stirewalt, MD, Paula A. Ladne, Era L. Pogosova-Agadjanyan, Marilyn L. Slovak, PhD, Cheryl L. Willman, MD, Shelly Heimfeld, PhD, David H. Boldt, MD, Jerald P. Radich, MD

Blood (2005) 106 (11): 336.

https://doi.org/10.1182/blood.V106.11.336.336

Published: 2005

NARROW

A Robust Long Non-Coding RNA Expression Classifier for Risk Stratification in Pediatric AML

Global Proteomic Profiling Identifies Novel Prognostic Factors in Undifferentiated Leukemia Blasts from Patients with NPM1 Mutations: A Previously Unreported Approach to Biomarker Discovery from the Fred Hutch and SWOG

Proteogenomic Characterization of Highly Enriched Viable Leukemic Blasts in Acute Myeloid Leukemia: A SWOG Report

Characteristics and Prognostic Effects of IDH Mutations across the Age Spectrum in AML: A Collaborative Analysis from COG, SWOG, and ECOG

Development and Performance of Risk Stratification Models for AML Patients Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG Report

Improved Prognostic Significance of Genomic and Transcriptional Biomarkers By Examining Enriched Populations of AML Blasts: A SWOG Report

Prognostic Significance Of NPM1 mutations In The Absence Of FLT3 -ITD in Older Patients With AML: A SWOG Report

Novel IL23R Splice Variant Is Associated with Worse Prognosis in Pediatric Patients with AML.

Novel IRF8 Splice Variants Are Validated As a New Prognostic Biomarker for Adverse Outcome in an Independent Population of Pediatric Patients with AML.

Expression Differences of Prognostic Biomarkers in Mononuclear Cells (MNCs) and Malignant Blasts of Acute Myeloid Leukemia (AML) Patients

Prognostic Significance of FLT3 and NPM1 Mutations in Adults of Age 18–60 with De Novo Acute Myeloid Leukemia (AML) on SWOG S0106 Study: A Study by FHCRC and SWOG

Over-Expression of Novel IRF8 Splice Variants Is Associated with a Significant Decrease In Relapse-Free Survival In Adult AML Patients.

Methylation Regulates Expression of Novel Splice Variant and Wild Type Transcripts of IRF8.

Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia

Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only